Get started
Author

Jayne M. Silver

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts
2013 · Krishan Kumar, Simon Wigfield, et al. · Journal of Molecular Medicine · 76
PDF
Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2015 · Eva Tonsing-Carter, Barbara J. Bailey, et al. · Molecular Cancer Therapeutics · 42
Virtual Screening Targeting the Urokinase Receptor, Biochemical and Cell-Based Studies, Synthesis, Pharmacokinetic Characterization, and Effect on Breast Tumor Metastasis
2011 · Fang Wang, Jing Li, et al. · Journal of Medicinal Chemistry · 34
Differential Secondary Reconstitution ofIn Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chainnullMice
2010 · Shanbao Cai, Haiyan Wang, et al. · Bone Marrow Research · 15
PDF
Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice
2014 · Harlan E. Shannon, Melissa L. Fishel, et al. · Pancreas · 8
NQO1-Bioactivatable Therapeutics as Radiosensitizers for Cancer Treatment
2020 · Naveen Singh, Edward A. Motea, et al. · IntechOpen eBooks · 1
PDF
Abstract 5373: Modulation of temozolomide-mediated DNA damage in glioblastoma multiforme by the HDM2 antagonist, nutlin3
2010 · Haiyan Wang, Shanbao Cai, et al. · Cancer Research · 1
Supplemental Figure S2 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S5 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S3 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S4 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S6 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S7 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S1 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Table S1, Supplemental Material and Methods and Supplemental Figure Legends from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Table S1, Supplemental Material and Methods and Supplemental Figure Legends from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S5 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S2 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S4 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S1 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S6 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S7 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Supplemental Figure S3 from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Data from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Data from Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model
2023 · Eva Tonsing-Carter, Barbara J. Bailey, et al.
Works count: 33
Citation count: 177
H-index: 5
I10-index: 4
Year
Topic
Type